FOSCARNET vs FOSTAMATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSCARNET vs FOSTAMATINIB: Safety Overview
| Metric | FOSCARNET | FOSTAMATINIB |
|---|---|---|
| Total FAERS Reports | 2,057 | 6,394 |
| Deaths Reported | 605 | 453 |
| Death Rate | 29.4% | 7.1% |
| Hospitalizations | 608 | 1,493 |
| Average Patient Age | 41.8 yrs | 64.7 yrs |
| % Female Patients | 40.6% | 60.8% |
| FDA Approval Date | Apr 21, 2021 | Apr 17, 2018 |
| Manufacturer | Hikma Pharmaceuticals USA Inc. | Rigel Pharmaceuticals, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |